FIELD: pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely to an agent for treating arthritic diseases. An agent for treating arthritic diseases comprising 50 to 2500 mg of chondroitin sodium sulphate and at least one auxiliary substance or carrier, also contains molybdenum in relative amount from 0.15 to 2 mg/kg in terms of weight of chondroitin sodium sulphate.
EFFECT: agent described above increases the bioavailability of the preparations of chondroitin sulphate in various forms by using it in combination with molybdenum, and also enables reducing the therapeutic course and reducing the negative side effects.
23 cl, 5 ex, 1 tbl, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739184C1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739747C1 |
| PHARMACEUTICAL AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2023 |
|
RU2813891C1 |
| COMBINED AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2024 |
|
RU2827069C1 |
| AGENT FOR TREATING ARTHROLOGICAL DISEASES IN LYOPHILIZED FORM FOR INJECTIONS | 2024 |
|
RU2827073C1 |
| LYOPHILISED PHARMACEUTICAL COMPOSITION FOR PREPARING SOLUTION FOR INJECTIONS FOR TREATING DEGENERATE-DYSTROPHIC LOCOMOTOR DISEASES AND METHOD FOR PREPARING IT | 2011 |
|
RU2458693C1 |
| AGENT FOR TREATMENT OF JOINT DISEASE | 2005 |
|
RU2282437C1 |
| REMEDY FOR TREATING DISEASES OF JOINTS | 2005 |
|
RU2275190C1 |
| AGENT FOR TREATMENT OF ARTHROLOGIC DISEASES | 2015 |
|
RU2612014C1 |
| PHARMACEUTICAL PREPARATION FOR TREATMENT OF ARTHROLOGICAL DISEASES | 2015 |
|
RU2743274C2 |
